Congestive Heart Failure (CHF)

In the United States alone approximately 6 million suffer from heart failure (HF). The EvidenceCare Congestive Heart Failure pathway provides recommendations on the diagnostic work-up, optimal therapeutic management, and disposition of the acutely decompensated heart failure based on their severity of disease and volume status. This pathway also includes a risk stratification tool to assist providers in disposition decisions of patients who are mildly decompensated and may be candidates for treatment at home. The Congestive Heart Failure pathway is based on the 2013 ACCF/AHA Guideline for Management of Heart failure, 2012 European Society of Cardiology guidelines for Acute and Chronic Heart Failure, the 2010 Heart Failure Society of America Comprehensive Practice Guideline, and 2009 Society of Chest Pain Centers recommendations.

Semhar Tewelde, MD
Read More

You May Also Like These Protocols


The EvidenceCare Pneumonia pathway allows the provider to determine the optimal treatment protocol for a patient with suspected Pneumonia. The…

Learn More

Small Bowel Bleeding

Bleeding from the small intestine remains a relatively uncommon event, accounting for ~5–10% of all patients presenting with gastrointestinal (GI)…

Learn More

Lower GI Bleeding

This guideline provides recommendations for the management of patients with acute overt lower gastrointestinal bleeding. Hemodynamic status should be initially…

Learn More